In addition to the cancer types expected to be affected by the IGFBP-3/TMEM219 system, bladder urothelial carcinoma and head and neck squamous cell carcinoma appear to be significantly associated with TMEM219 but not with IGFBP-3 expression. This evidence concerns the gene TMEM219 and cancer.